Generic Pharmaceutical Business Investment Opportunities

Business is located in Bhubaneswar, specializing in the development of drugs that induce endogenous nitric oxide in humans and animals. - Company is incubated in a well-known biotechnological institute in Bhubaneswar, Orissa. - Company has successfully completed the research to identify the chemical structure of the drug that can induce nitric oxide production and is now seeking funding to proceed with development. - Research findings are patented and protected in India, USA, and EU, providing the company with a competitive advantage in the market. - The company is ready to commence the development phase upon securing the necessary funding, presenting an opportunity for potential investors to participate in an innovative and potentially lucrative venture in the pharmaceutical and nutraceutical industry. - Promoter is a medical researcher and has 50 years of experience. - The company is registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with regulatory and legal requirements.

The business operates in the pharmaceutical and medical devices export industry, focusing on therapies such as anaemia management, nephrology, and gynaecology. - With a current staff of 6 permanent employees, the business has made significant strides in increasing its client base, growing from 2 clients in the last fiscal year to 15 clients in the current fiscal year. - The company has outlined a road-map to achieve a turnover of 100 crore in the next 2 fiscal years, indicating a strong growth trajectory. - Initially starting as a short-term trading model, the business is now transitioning towards brand building and is in the process of registering its brand in 4 countries, showcasing a strategic shift in its business model. - The product portfolio comprises 80% medicines and 20% medical devices, with a focus on exporting these products to countries such as Zambia, Uganda, and Kenya. - The business sources medicines and equipment from India and exports them to international markets, highlighting its role in facilitating the global distribution of pharmaceutical and medical devices. - With a valid GST certificate for operations, the business is compliant with regulatory requirements, adding a layer of credibility to its operations.

Pharma manufacturing company, located in Nashik. - The plant is in its final stage of commissioning and will focus on the production of small volume parenterals in ampules, vials, PFS, and lyophilized products. - Technical inspection is pending, post which the business can obtain drug manufacturing license to start the manufacturing process. - Will be manufactured on a principle-to-principle and loan license basis for both local and export markets. - The product line includes human injectable products falling under drug categories such as antibiotics, steroids, analgesics etc. - Business model involves manufacturing products under the brand and formulation of other major pharmaceutical companies and supplying them for marketing and distribution. - The business is registered with the Ministry of Corporate Affairs (MCA), holds a Permanent Account Number (PAN), and is registered with the Micro, Small, and Medium Enterprises (MSME).

Business owner of a drug wholesale business planning to establish a pharmaceutical drug manufacturing plant. - The focus will be on creating a portfolio of drugs under the company's own brand name. - Initially, the manufacturing will concentrate on oral tablets and capsules, with future plans for expansion into other drug categories. - The company aims to supply its products to distributors across West Bengal, Jharkhand, Bihar, and Odisha. - Raw materials for the manufacturing process will be sourced from Ahmedabad and Visakhapatnam. - Will be obtaining drug license and FDA approval once the business launches.

Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management. - The brand, licenses, registrations, client base, and property have been transferred to the new owners. - Was supplying across Bangladesh, the Middle East, and African countries under its own branding. - The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production. - With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution. - The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs. - Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc. - The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets. - Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success. - The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization. - Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand. - Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.

The project is to manufacture and supply tablets to the government of Sri Lanka up to 860mln per annum on a buyback guarantee and cost plus 20% margin. - The company can sell also in the private market which has a 40% profit margin. - Own 9.25-acre land valued at USD 1mln approx. - The license is issued and a government buyback agreement is signed. - The project is in plug and play stage where the investor can mobilize immediately. - Commercial manufacturing can commence in 8 months.

API manufacturing company based in Indore, India. For the past 3 decades, this company has focused on API development, manufacturing, and marketing of APIs and intermediates. It has a state-of-the-art manufacturing facility and is a state GMP-certified plant facility. - This is a research-driven organization – that develops technology, translates it to production, and then delivers it to customers. With a strong commitment to excellence in product quality (which is never compromised) and adherence to strict delivery schedules, they are presently exporting to 14 countries around the world. - The company’s strength lies in providing extended support to its customers. Their success has been validated by what they hold the dearest – product excellence and customer service. The company believes that long-term business is rooted in values and business ethics. - It is one of the leading manufacturers of Tinidazole and Ornidazole, which are considered anti-protozoal molecules, a segment of bulk drugs. Sales have shown an increasing trend. - The company has received Good Manufacturing Practices (GMP) Certificate from the Office of the Controller of Food and Drugs Administration, Madhya Pradesh. Note: this transaction is being handled by an advisory firm based in Rajkot.

Our research and development department reflects our full commitment to delivering to society. - The revolutionary pharmaceuticals, acquired through groundbreaking ideas and high-standard research and development by each individual employee challenge innovation, so as to help enable patients and their families to lead healthier and more fulfilling lives. It also expresses our corporate mission symbolically, cooperating with a wide range of companies worldwide. - With a wide variety of drugs and a tradition in manufacturing for needs, we have cooperated with companies from Spain, Italy, and Turkey, looking forward to offering a wide range of healthcare products, also for well-being, with pre-ordered dosage forms for your efficiency and gut health. - The promoter is an investor representing the company who is based out of Istanbul.

We are an Oman-based company, with offices in the UK and India, manufacturing our own products in a GMP-certified European facility. - The formulations are done by us and the production is outsourced. - Currently, 7 SKUs/products have been launched in Oman. - We are ready to launch the products in other GCC countries and need funds to start operations in the GCC region immediately. - Our products had an excellent response in Oman. - Our sister concern is the distributor for Oman, and we have appointed one distributor for each GCC country. - The full company name and other details are to be shared upon connecting and assessing the investor. - Promoters have 13 years of experience in the field. - The business holds the necessary certificate from the health authority.